84 / 1498
0 2 4 6
SWOG: CHOP
vs
3 intensive
regimens in advanced NHL
Patients
3-year estimate (%)
at risk
225
54
223
52
233
50
218
50
p
= 0.90
Fischer
et al. NEJM
1993; 328: 1002–6
Years after randomization
% of treatment group
CHOP
m-BACOD
ProMACE-CytaBOM
MACOP-B
100
80
60
40
20
0